Following targeted routine antenatal <scp>anti‐D</scp> prophylaxis, almost half of the pregnant women had undetectable <scp>anti‐D</scp> prophylaxis at delivery-Reference-Cited by-同舟云学术

Following targeted routine antenatal anti‐D prophylaxis, almost half of the pregnant women had undetectable anti‐D prophylaxis at delivery

Published:2022-02-27 Issue:4 Volume:101 Page:431-440
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Sørensen Kirsten¹^ORCID,Stjern Helena Eriksson²^ORCID,Karlsen Bente Anita Grande²,Tomter Geir¹,Ystad Inger²,Herud Ida¹,Bævre Mette Silihagen¹,Llohn Abid Hussain²,Akkök Çiğdem Akalın¹^ORCID

Affiliation:

1. Department of Immunology and Transfusion Medicine Oslo University Hospital Oslo Norway

2. Department of Immunology and Transfusion Medicine Akershus University Hospital Lørenskog Norway

Funder

Akershus Universitetssykehus

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aogs.14328

Reference22 articles.

1. The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis

2. Norwegian Society of Gynecology and Obstetrics (Norsk gynekologisk forening).Veileder i fødselshjelp ‐ Alloimmunisering mot erytrocytt‐antigener (The Norwegian national guidelines for obstetrics ‐RBC alloimmunization) 2020 [cited 2021 09.06.]. Available from:https://www.legeforeningen.no/foreningsledd/fagmed/norsk‐gynekologisk‐forening/veiledere/veileder‐i‐fodselshjelp‐2020/alloimmunisering‐mot‐erytrocytt‐antigener/.

3. Arentz‐HansenH BrurbergKG KvammeMK et al.NIPH systematic reviews. Determination of fetal rhesus D status from maternal plasma of rhesus negative women. Oslo Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH);2014.

4. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

5. No. 133-Prevention of Rh Alloimmunization

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?;Transfusion and Apheresis Science;2024-08

2. Comparison of the Detection Rate and Specificity of Irregular Red Blood Cell Antibodies Between First-Time Pregnant Women and Women With a History of Multiple Pregnancies Among 18,010 Chinese Women;Journal of Pregnancy;2024-05-31

3. Guideline No. 448: Prevention of Rh D Alloimmunization;Journal of Obstetrics and Gynaecology Canada;2024-04

4. Directive clinique no 448 : Prévention de l’allo-immunisation Rhésus D;Journal of Obstetrics and Gynaecology Canada;2024-04

5. Application of anti-D immunoglobulin in D-negative pregnant women in China;Transfusion Clinique et Biologique;2024-02